Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Physical exercise · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Combined Aerobic and Resistance Exercise Program: perform three exercise sessions per week consisting of about 25-30 minutes of aerobic exercise at a moderate-to-vigorous intensity as well as some weight training consisting of two sets of 8-12 repetitions of 9-10 different exercises. For the aerobic exercise, participant can choose from different exercise equipment such as a treadmill or stationary bicycle. |
| 2 | ACTIVE_COMPARATOR | Moderate Aerobic Exercise Group: perform three exercise sessions per week consisting of about 25-30 minutes of aerobic exercise at a moderate-to-vigorous intensity. Again, participant can choose from different exercise equipment. |
| 3 | EXPERIMENTAL | High Aerobic Exercise Group: perform three exercise sessions per week consisting of about 45-60 minutes of aerobic exercise at a moderate-to-vigorous intensity. Again, participant can choose from different exercise equipment. |
| Name | Type | Description |
|---|---|---|
| Physical exercise | BEHAVIORAL | perform exercise program 3 days per week and 5 minutes of warm-up and cool-down exercises before and after the main exercise component |
* Are diagnosed with stage I-IIIA breast cancer, histologically confirmed * Are scheduled to receive adjuvant chemotherapy (receiving neoadjuvant chemotherapy for locally advanced cancer is an exclusion criteria) * Have not received previous chemotherapy (previous cancer is NOT an exclusion criteria...
Top 20 of 92 competitors
Physical exercise is being studied as an intervention for breast cancer survivors. A Phase 3 clinical trial evaluated the effects of combined aerobic and resistance exercise in this population. The study enrolled 301 female participants aged 18 years and older in Canada and has been completed.
Physical exercise is being developed by Avalon GloboCare Corp., a company listed on the stock exchange under the ticker ALBT. The company is conducting clinical research to evaluate the potential benefits of exercise as an intervention for breast cancer survivors.
Physical exercise is in Phase 3 clinical development for breast cancer. One Phase 3 trial has been completed, which enrolled 301 participants. The study was randomized and active-controlled, meaning it compared the exercise intervention against an active control group.
Physical exercise has one completed clinical trial registered under NCT00249015, titled 'Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors.' This Phase 3 study enrolled 301 female participants in Canada and evaluated the intervention's effects in breast cancer survivors.
Physical exercise is an investigational intervention still in clinical development for breast cancer. It has completed a Phase 3 trial, but approval status has not been established. The intervention remains under study and is not confirmed as an approved treatment.